These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 12209708)

  • 1. Treatment of micropapillary serous ovarian carcinoma (the aggressive variant of serous borderline tumors).
    Seidman JD; Kurman RJ
    Cancer; 2002 Aug; 95(4):675-6. PubMed ID: 12209708
    [No Abstract]   [Full Text] [Related]  

  • 2. Is micropapillary serous carcinoma for real?
    Gershenson DM
    Cancer; 2002 Aug; 95(4):677-80. PubMed ID: 12209709
    [No Abstract]   [Full Text] [Related]  

  • 3. Borderline epithelial tumors of the ovary.
    Hart WR
    Mod Pathol; 2005 Feb; 18 Suppl 2():S33-50. PubMed ID: 15761465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian serous neoplasms of low malignant potential associated with focal areas of serous carcinoma.
    Silva EG; Tornos CS; Malpica A; Gershenson DM
    Mod Pathol; 1997 Jul; 10(7):663-7. PubMed ID: 9237175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skin metastases revealing a bilateral ovarian invasive micropapillary serous carcinoma.
    Moussa A; Denguezli W; Njim L; Haddad A; Faleh R; Sakouhi M; Zakhama A
    Arch Gynecol Obstet; 2008 Jul; 278(1):71-4. PubMed ID: 18066568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian serous borderline tumors with micropapillary and cribriform patterns: a study of 40 cases and comparison with 44 cases without these patterns.
    Eichhorn JH; Bell DA; Young RH; Scully RE
    Am J Surg Pathol; 1999 Apr; 23(4):397-409. PubMed ID: 10199469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of the micropapillary pattern in patients with serous borderline ovarian tumors.
    Chang SJ; Ryu HS; Chang KH; Yoo SC; Yoon JH
    Acta Obstet Gynecol Scand; 2008; 87(4):476-81. PubMed ID: 18382877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bilateral micropapillary serous carcinoma of the ovary: a case report.
    Gupta R; Singh S; Nigam S
    Arch Gynecol Obstet; 2007 May; 275(5):401-4. PubMed ID: 17031658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
    Silva EG; Gershenson DM; Malpica A; Deavers M
    Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subclassification of serous borderline tumors of the ovary into benign and malignant types. A clinicopathologic study of 65 advanced stage cases.
    Seidman JD; Kurman RJ
    Am J Surg Pathol; 1996 Nov; 20(11):1331-45. PubMed ID: 8898837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnostic difficulties in serous "borderline" tumors of the ovary].
    Vereczkey I; Tóth E; Orosz Z
    Magy Onkol; 2009 Mar; 53(1):23-31. PubMed ID: 19318323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Serous micropapillary invasive carcinoma. Case report on both ovaries].
    Espinosa de los Monteros Franco VA; Padilla Rodríguez AL
    Ginecol Obstet Mex; 2007 Nov; 75(11):682-6. PubMed ID: 18697443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Strategy and outcome of interdisciplinary therapy of ovarian carcinomas].
    Ruf C; Kohlberger E; Bauknecht T; Farthmann EH
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1494-6. PubMed ID: 9931922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of ovarian serous papillary adenocarcinoma combined with malignant endosalpingiosis].
    Mizutani H; Katabuchi H; Nakamura M; Matsuura K; Ito M; Okamura H
    Nihon Sanka Fujinka Gakkai Zasshi; 1993 Oct; 45(10):1139-42. PubMed ID: 8245594
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
    Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
    Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microdissection-based mutational genotyping of serous borderline tumors of the ovary.
    Krishnamurti U; Sasatomi E; Swalsky PA; Jones MW; Finkelstein SD
    Int J Gynecol Pathol; 2005 Jan; 24(1):56-61. PubMed ID: 15626917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microinvasion links ovarian serous borderline tumor and grade 1 invasive carcinoma.
    Hogg R; Scurry J; Kim SN; Friedlander M; Hacker N
    Gynecol Oncol; 2007 Jul; 106(1):44-51. PubMed ID: 17467045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results after conservative treatment of serous borderline tumors of the ovary with a micropapillary pattern.
    Laurent I; Uzan C; Gouy S; Pautier P; Duvillard P; Morice P
    Ann Surg Oncol; 2008 Dec; 15(12):3561-6. PubMed ID: 18820973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diverse tumorigenic pathways in ovarian serous carcinoma.
    Singer G; Kurman RJ; Chang HW; Cho SK; Shih IeM
    Am J Pathol; 2002 Apr; 160(4):1223-8. PubMed ID: 11943707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative analysis of 57 serous borderline tumors with and without a noninvasive micropapillary component.
    Slomovitz BM; Caputo TA; Gretz HF; Economos K; Tortoriello DV; Schlosshauer PW; Baergen RN; Isacson C; Soslow RA
    Am J Surg Pathol; 2002 May; 26(5):592-600. PubMed ID: 11979089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.